Novo Nordisk A/S (VIE:NNO2)
40.49
-8.38 (-17.16%)
At close: Feb 4, 2026
Novo Nordisk Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 309,064 | 290,403 | 232,261 | 176,954 | 140,800 | |
Revenue Growth (YoY) | 6.43% | 25.03% | 31.25% | 25.68% | 10.91% |
Cost of Revenue | 55,734 | 43,560 | 35,319 | 28,424 | 23,658 |
Gross Profit | 253,330 | 246,843 | 196,942 | 148,530 | 117,142 |
Selling, General & Admin | 67,870 | 67,368 | 61,594 | 50,683 | 41,058 |
Research & Development | 48,136 | 40,072 | 31,075 | 23,263 | 17,199 |
Other Operating Expenses | 300 | -476 | -425 | -1,034 | -332 |
Operating Expenses | 116,306 | 106,964 | 92,244 | 72,912 | 57,925 |
Operating Income | 137,024 | 139,879 | 104,698 | 75,618 | 59,217 |
Interest Expense | -6,778 | -1,640 | -542 | -378 | -289 |
Interest & Investment Income | 9,660 | 1,838 | 1,069 | 239 | 231 |
Earnings From Equity Investments | - | -17 | 81 | -189 | -24 |
Currency Exchange Gain (Loss) | - | -1,023 | 1,652 | -4,651 | 344 |
Other Non Operating Income (Expenses) | - | -289 | -197 | -181 | -122 |
EBT Excluding Unusual Items | 139,906 | 138,748 | 106,761 | 70,458 | 59,357 |
Merger & Restructuring Charges | -6,589 | -978 | - | - | - |
Gain (Loss) on Sale of Investments | - | -17 | 37 | -587 | 296 |
Asset Writedown | -2,353 | -10,562 | -2,124 | -809 | -573 |
Other Unusual Items | -424 | - | - | - | - |
Pretax Income | 130,540 | 127,191 | 104,674 | 69,062 | 59,080 |
Income Tax Expense | 28,106 | 26,203 | 20,991 | 13,537 | 11,323 |
Net Income | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income to Common | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income Growth | 1.43% | 20.68% | 50.71% | 16.27% | 13.33% |
Shares Outstanding (Basic) | 4,442 | 4,454 | 4,483 | 4,531 | 4,593 |
Shares Outstanding (Diluted) | 4,448 | 4,463 | 4,495 | 4,545 | 4,606 |
Shares Change (YoY) | -0.34% | -0.71% | -1.10% | -1.34% | -1.58% |
EPS (Basic) | 23.06 | 22.67 | 18.67 | 12.26 | 10.40 |
EPS (Diluted) | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 |
EPS Growth | 1.77% | 21.54% | 52.37% | 17.84% | 15.16% |
Free Cash Flow | 58,962 | 73,804 | 83,102 | 66,741 | 48,665 |
Free Cash Flow Per Share | 13.26 | 16.54 | 18.49 | 14.69 | 10.56 |
Dividend Per Share | 11.700 | 11.400 | 9.400 | 6.200 | 5.200 |
Dividend Growth | 2.63% | 21.28% | 51.61% | 19.23% | 14.29% |
Gross Margin | 81.97% | 85.00% | 84.79% | 83.94% | 83.20% |
Operating Margin | 44.34% | 48.17% | 45.08% | 42.73% | 42.06% |
Profit Margin | 33.14% | 34.77% | 36.03% | 31.38% | 33.92% |
Free Cash Flow Margin | 19.08% | 25.41% | 35.78% | 37.72% | 34.56% |
EBITDA | 151,690 | 146,669 | 110,523 | 81,119 | 63,770 |
EBITDA Margin | 49.08% | 50.51% | 47.59% | 45.84% | 45.29% |
D&A For EBITDA | 14,666 | 6,790 | 5,825 | 5,501 | 4,553 |
EBIT | 137,024 | 139,879 | 104,698 | 75,618 | 59,217 |
EBIT Margin | 44.34% | 48.17% | 45.08% | 42.73% | 42.06% |
Effective Tax Rate | 21.53% | 20.60% | 20.05% | 19.60% | 19.17% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.